Literature DB >> 17698646

Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming.

Matthew A Fischer1, David C Tscharke, Keri B Donohue, Mary E Truckenmiller, Christopher C Norbury.   

Abstract

Viral vectors have been shown to induce protective CD8(+) T-cell populations in animal models, but significant obstacles remain to their widespread use for human vaccination. One such obstacle is immunodominance, where the CD8(+) T-cell response to a vector can suppress the desired CD8(+) T-cell response to a recombinantly encoded antigen. To overcome this hurdle, we broadly reduced vector-specific gene expression. We treated a recombinant vaccinia virus, encoding antigen as a minimal peptide determinant (8-10 aa), with psoralen and short-wave UV light. The resulting virus induced 66 % fewer vector-specific immunodominant CD8(+) T cells, allowing the in vivo induction of an increased number of CD8(+) T cells specific for the recombinant antigen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698646     DOI: 10.1099/vir.0.83107-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Authors:  John T Hunzeker; Michael D Elftman; Jennifer C Mellinger; Michael F Princiotta; Robert H Bonneau; Mary E Truckenmiller; Christopher C Norbury
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 2.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

3.  Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.

Authors:  Lauren W Kaminsky; Janet J Sei; Nikhil J Parekh; Michael L Davies; Irene E Reider; Tracy E Krouse; Christopher C Norbury
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

4.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

5.  Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration.

Authors:  Anju Bansal; Bethany Jackson; Kim West; Shixia Wang; Shan Lu; Jeffrey S Kennedy; Paul A Goepfert
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

6.  An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.

Authors:  Lichen Jing; D Huw Davies; Tiana M Chong; Sookhee Chun; Christopher L McClurkan; Jay Huang; Brian T Story; Douglas M Molina; Siddiqua Hirst; Philip L Felgner; David M Koelle
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

7.  Systemic toll-like receptor ligation and selective killing of dendritic cell subsets fail to dissect priming pathways for anti-vaccinia virus CD8⁺ T cells.

Authors:  Yik Chun Wong; Stewart A Smith; David C Tscharke
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

8.  Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.

Authors:  Erica L Heipertz; Michael L Davies; Eugene Lin; Christopher C Norbury
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

9.  Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Authors:  David A Garber; Leigh A O'Mara; Jun Zhao; Sailaja Gangadhara; InChul An; Mark B Feinberg
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

10.  Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.

Authors:  Janet J Sei; Scott Haskett; Lauren W Kaminsky; Eugene Lin; Mary E Truckenmiller; Clifford J Bellone; R Mark Buller; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2015-06-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.